Versor Investments LP Takes Position in Agilent Technologies, Inc. (NYSE:A)

Versor Investments LP acquired a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 8,546 shares of the medical research company's stock, valued at approximately $1,269,000.

Several other hedge funds and other institutional investors also recently modified their holdings of A. Crewe Advisors LLC boosted its position in shares of Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company's stock valued at $25,000 after purchasing an additional 101 shares in the last quarter. Livelsberger Financial Advisory bought a new stake in Agilent Technologies during the third quarter worth about $28,000. Ridgewood Investments LLC purchased a new position in Agilent Technologies during the 2nd quarter valued at about $29,000. Ashton Thomas Securities LLC bought a new stake in shares of Agilent Technologies in the 3rd quarter worth approximately $31,000. Finally, Fortitude Family Office LLC lifted its position in Agilent Technologies by 68.3% in the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company's stock valued at $35,000 after acquiring an additional 95 shares in the last quarter.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the business's stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the sale, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, SVP Dominique Grau sold 9,990 shares of the company's stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at approximately $5,801,595. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 11,995 shares of company stock worth $1,739,510.

Agilent Technologies Price Performance

A stock traded down $0.20 during trading on Tuesday, hitting $133.66. 1,490,442 shares of the stock traded hands, compared to its average volume of 1,704,506. Agilent Technologies, Inc. has a one year low of $106.96 and a one year high of $155.35. The stock has a market cap of $38.40 billion, a price-to-earnings ratio of 27.77, a P/E/G ratio of 6.01 and a beta of 1.07. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The company has a 50 day simple moving average of $139.27 and a 200 day simple moving average of $138.19.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping analysts' consensus estimates of $1.26 by $0.06. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The firm's revenue for the quarter was down 5.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.43 earnings per share. Equities analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were issued a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a dividend yield of 0.71%. The ex-dividend date of this dividend was Tuesday, October 1st. Agilent Technologies's dividend payout ratio (DPR) is presently 19.50%.

Analyst Upgrades and Downgrades

Several research analysts have commented on A shares. Citigroup increased their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a "buy" rating in a report on Thursday, August 22nd. TD Cowen lifted their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a "buy" rating in a report on Thursday, August 22nd. Evercore ISI boosted their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 1st. Barclays increased their price objective on Agilent Technologies from $135.00 to $145.00 and gave the company an "underweight" rating in a research note on Tuesday, October 15th. Finally, Stifel Nicolaus reiterated a "buy" rating and set a $151.00 target price on shares of Agilent Technologies in a research report on Monday, August 26th. One analyst has rated the stock with a sell rating, five have issued a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $144.36.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.